AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

$18.17
-0.29 (-1.57%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +535.9% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $18.17
Current
$18.17
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
260.1%
Low target
Base Case
$115.54
+535.9%
Avg target
Bull Case
$156.42
+760.9%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$19.26
-5.7% from high
52-Week Low
$7.67
+137.1% from low
50-Day SMA
$13.39
+35.7% vs SMA
200-Day SMA
$10.30
+76.4% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+499.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +11.9%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +16.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.8%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +30.5%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +172.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +173.7%